Europe Nerve Repair & Regeneration Market

The nerve repair & regeneration market in Europe is expected to grow from US$ 1,537.23 million in 2022 to US$ 2,709.29 million by 2028; it is estimated to grow at a CAGR of 9.9% from 2022 to 2028.

Rising Prevalence of Age-associated Neurological Disorders among Geriatric Population Boosts Europe Nerve Repair & Regeneration Market Growth

Some neurologic disorders such as neuropathy, Alzheimer's disease, Parkinson's disease, and strokes are more common in the elderly, and their prevalence is increasing with higher life expectancies. According to the WHO, the population is aging rapidly worldwide. Between 2015 and 2050, the world's population over 60 years will nearly double, from 12% to 22%, and mental and neurological disorders among older adults are likely to account for 6.6% of the total disability-adjusted life year (DALYs) for this age group. Also, as per the same source, approximately 15% of adults aged 60 and over have a mental disorder. The death rate due to neurological disorders is also increasing. For instance, according to the Alzheimer's Association, 1 in 3 seniors dies with Alzheimer's or dementia. Therefore, rising prevalence of age-associated neurological disorders increases demand for treatment of nerve repair & regeneration. This factor is propelling the growth of nerve repair & regeneration market.

Market Overview

The Europe nerve repair & regeneration market is further segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. The Europe nerve repair & regeneration market growth is attributed to the growing geriatric population, increasing incidence of neurological disorders, high incidence of nerve injuries, and rising government support for neurological disorder studies. According to the German Alzheimer Society, in 2021, ~1.6 million people in Germany had dementia, and ~300,000 new cases are detected every year. Furthermore, the aging population is expected to increase from 2.4 in 2021 to 2.8 million by 2050, which is a major cause of dementia. Similarly, Parkinson’s disease is the second most common neurodegenerative disorder, which causes disability and movement disorder. According to Acta Neruologica Scandinavica, the number of people diagnosed with Parkinson’s disease will be doubled by 2050 in Europe. According to the German Society of Neurology, the prevalence of Parkinson’s disease is 1800 in every 100,000 persons. To control the growing prevalence of neurological disorders, the German Center for Neurodegenerative Diseases (DZNE) is investigating the major cause of nervous system diseases and various approaches for prevention, therapy, and care. Further, the DZNE, in collaboration with their university partners, promotes young researchers in studies of neurological disorders. Thus, the growing prevalence of neurological diseases and government-supported initiatives to combat the disease are driving the growth of the Europe nerve repair & regeneration market.

Europe Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)

Europe Nerve Repair & Regeneration Strategic Insights

Strategic insights for the Europe Nerve Repair & Regeneration provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Nerve Repair & Regeneration Report Scope

Europe Nerve Repair & Regeneration Regional Insights

The geographic scope of the Europe Nerve Repair & Regeneration refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Europe Nerve Repair & Regeneration Market Segmentation

The Europe nerve repair & regeneration market is bifurcated on the basis of product and application.

• Based on product, the Europe nerve repair & regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment accounted for a larger market share in 2022.
• Based on application, the Europe nerve repair & regeneration market is bifurcated into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held a larger market share in 2022. 
• Based on country, the Europe nerve repair & regeneration market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Further, Germany dominated the market in 2022.

Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in Europe.